Rennova Health, Inc. Granted U.S. Trademark for StableSpot(R), a Laboratory Specimen Transport Syste

Rennova Health, Inc. Granted U.S. Trademark for StableSpot(R), a Laboratory Specimen Transport System

ID: 447271

New System Will Lead to Drastic Reduction in Laboratory Supply Costs


(firmenpresse) - WEST PALM BEACH, FL -- (Marketwired) -- 01/28/16 -- Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), which owns and operates a diverse family of healthcare companies, received a trademark from the United States Patent and Trademark Office for StableSpot®, a clinical dry specimen transport kit for collection, stabilization, and transport of urine, serum, plasma, and blood. This innovative new approach will provide convenient sample collection for a patient, help protect the integrity of samples, cut down on packing and shipping concerns, and reduce total laboratory supply costs.

"One of the greatest challenges to providing a diagnostic service directly to an individual is the collection, transport and maintaining the stability of specimens," remarked Seamus Lagan, CEO of Rennova Health, Inc. "StableSpot® provides a viable solution to an area in our business that has historically been complicated and costly."

As well as the inconvenient traditional collection methods, many laboratory specimens require stabilization, refrigeration, and/or freezing in order to maintain specimen stability during transit. To mitigate against specimen degradation, shipments would contain ice packs, coolers, and other special shipping equipment. Now, StableSpot's technology allows dry specimens to take the place of liquid ones.

StableSpot® Dry-Specimen Collection Kits will be used by Rennova Health, Inc., at their five clinical reference laboratories nationwide. For more information about StableSpot® and Rennova Health, please contact Sebastien Sainsbury at (561) 666-9818 or .



(NASDAQ: RNVA) provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcome. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information about Rennova Health, Inc., visit .







Rennova Health Media Contact:

Sebastien Sainsbury
(561) 666-9818


Investors:
LHA
Kim Golodetz
(212) 838-3777


Or

Bruce Voss
(310) 691-7100


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  First Choice Healthcare Announces New Comprehensive Corporate Communications Strategy DiaMedica Provides Update on DM199 Opportunity in South East Asia
Bereitgestellt von Benutzer: Marketwired
Datum: 28.01.2016 - 22:00 Uhr
Sprache: Deutsch
News-ID 447271
Anzahl Zeichen: 0

contact information:
Town:

WEST PALM BEACH, FL



Kategorie:

Hospitals, Facilities and Providers



Diese Pressemitteilung wurde bisher 268 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Rennova Health, Inc. Granted U.S. Trademark for StableSpot(R), a Laboratory Specimen Transport System"
steht unter der journalistisch-redaktionellen Verantwortung von

Rennova Health, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Rennova Health, Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z